STOCK TITAN
  1. Home
  2. News
  3. PRTC

PureTech Health Plc - PRTC STOCK NEWS

IMPACT
SENTIMENT
PRTC : Nasdaq KRTX : Nasdaq
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
IMPACT
SENTIMENT
PRTC : Nasdaq KRTX : Nasdaq
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
clinical trial
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers
clinical trial
IMPACT
SENTIMENT
PRTC : Nasdaq KRTX : Nasdaq AKLI : Nasdaq
PureTech to Present at Two Upcoming Investor Conferences
conferences
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation
clinical trial
IMPACT
SENTIMENT
PRTC : Nasdaq KRTX : Nasdaq
KarXT, invented at PureTech, submitted for FDA Approval in Schizophrenia
fda approval
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Announces the Appointment of Robert Lyne as Chief Portfolio Officer
management
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Health: Notice of Half-Yearly Results
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome
Stock PRTC logo
PureTech Health Plc

Nasdaq:PRTC

PRTC Rankings

#3478 Ranked by Market Cap
#3907 Ranked by Stock Gains
N/A Ranked by Dividends

PRTC Stock Data

Investment Advice
Finance and Insurance
Link
US
Boston

About PRTC

PureTech Health is a biotechnology company which develops medicines to combat serious diseases.